The RAL Small G Proteins Are Clinically Relevant Targets in Triple Negative Breast Cancer

David K. Han(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Steven T. Sizemore(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cancers
August 31, 2024
10.3390/cancers16173043
Cited by 3

Related Papers

The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer
|Breast Cancer Research|2021|17
The Small G-Protein RalA Promotes Progression and Metastasis of Triple Negative Breast Cancer
|Research Square|2021|0
Abstract P4-12-28: Discovery and Validation of Novel Small G Protein Inhibitor OSURALi for Targeting Triple Negative Breast Cancer
|Clinical Cancer Research|2025|0